These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15753451)

  • 21. A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine.
    Bartolini M; Giamberardino MA; Lisotto C; Martelletti P; Moscato D; Panascia B; Savi L; Pini LA; Sances G; Santoro P; Zanchin G; Omboni S; Ferrari MD; Brighina F; Fierro B
    J Headache Pain; 2011 Jun; 12(3):361-8. PubMed ID: 21437714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-acting triptans and weather-related migraines.
    Jacobs HS
    Headache; 2014 Jan; 54(1):167-8. PubMed ID: 24400756
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline.
    Kelman L; Harper SQ; Hu X; Campbell JC
    Curr Med Res Opin; 2010 Sep; 26(9):2097-104. PubMed ID: 20642390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triptans to the rescue: effective therapy for migraine headaches in the workplace.
    Bartleson JD
    Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.
    Tullo V; Valguarnera F; Barbanti P; Cortelli P; Sette G; Allais G; d'Onofrio F; Curone M; Zava D; Pezzola D; Benedetto C; Frediani F; Bussone G
    Cephalalgia; 2014 May; 34(6):434-45. PubMed ID: 24363238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early (≤ 1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study.
    Allais G; Bussone G; Tullo V; Cortelli P; Valguarnera F; Barbanti P; Sette G; Frediani F; D'Arrigo G; d'Onofrio F; Comi G; Curone M; Colombo B; Omboni S; Benedetto C
    Neurol Sci; 2015 May; 36 Suppl 1():161-7. PubMed ID: 26017535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Frovatriptan possibly causing acute myocardial infarction].
    Møller-Helgestad OK; Kaltoft AK; Kasch H
    Ugeskr Laeger; 2015 Mar; 177(13):V10140537. PubMed ID: 25822816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic evaluation of frovatriptan.
    Negro A; Lionetto L; Casolla B; Lala N; Simmaco M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan.
    Allais G; Bussone G; Airola G; Borgogno P; Gabellari IC; De Lorenzo C; Pavia E; Benedetto C
    Neurol Sci; 2008 May; 29 Suppl 1():S186-90. PubMed ID: 18545931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
    Brandes JL; Smith T; Diamond M; Ames MH
    Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
    Cady RK; Banks J; Jones BA; Campbell J
    Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.
    Allais G; Bussone G; D'Andrea G; Moschiano F; d'Onofrio F; Valguarnera F; Manzoni GC; Grazzi L; Allais R; Benedetto C; Acuto G
    Cephalalgia; 2011 Jan; 31(2):144-51. PubMed ID: 20660540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
    Brandes JL; Poole Ac; Kallela M; Schreiber CP; MacGregor EA; Silberstein SD; Tobin J; Shaw R
    Cephalalgia; 2009 Nov; 29(11):1133-48. PubMed ID: 19811503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study.
    Spierings EL; Keywood C
    Pain Med; 2009; 10(4):633-8. PubMed ID: 19453958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frovatriptan.
    Easthope SE; Goa KL
    CNS Drugs; 2001; 15(12):969-76; discussion 977-8. PubMed ID: 11735616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of migraine treatment: a commentary.
    Smith DG
    Value Health; 2003; 6(4):436-7. PubMed ID: 12859584
    [No Abstract]   [Full Text] [Related]  

  • 37. Frovatriptan plus dexketoprofen in the treatment of menstrually related migraine: an open study.
    Allais G; Rolando S; Schiapparelli P; Airola G; Borgogno P; Mana O; Benedetto C
    Neurol Sci; 2013 May; 34 Suppl 1(Suppl 1):S179-81. PubMed ID: 23695075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the 'Act when Mild' study.
    Slof J
    Appl Health Econ Health Policy; 2012 May; 10(3):201-15. PubMed ID: 22320449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 40. Case Report: Rizatriptan-Induced Ischemic Colitis.
    Fonseka GR; Kurchin A
    Headache; 2015; 55(7):1008-9. PubMed ID: 25881718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.